AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRAX
  4. [8-K] Praxis Precision Medicines, Inc. Reports Material Event

[8-K] Praxis Precision Medicines, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock PRAX logo
Praxis Precision Medicines, Inc.

NASDAQ:PRAX

PRAX Rankings

#3516 Ranked by Market Cap
N/A Ranked by Dividends

PRAX Latest News

Aug 4, 2025
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
Aug 4, 2025
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Aug 4, 2025
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
Jul 29, 2025
Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results
Jul 17, 2025
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies

PRAX Latest SEC Filings

Aug 4, 2025
[8-K] Praxis Precision Medicines, Inc. Reports Material Event
Aug 4, 2025
[10-Q] Praxis Precision Medicines, Inc. Quarterly Earnings Report
Jul 22, 2025
[SCHEDULE 13G] Praxis Precision Medicines, Inc. SEC Filing
Jun 27, 2025
[8-K] Praxis Precision Medicines, Inc. Reports Material Event
Jun 27, 2025
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity

PRAX Stock Data

1.10B
18.96M
0.16%
125.29%
9.53%
Biotechnology
Pharmaceutical Preparations
United States
BOSTON